DZ2613A1 - Nouveaux composés de pipérazine et de pipéridine. - Google Patents

Nouveaux composés de pipérazine et de pipéridine.

Info

Publication number
DZ2613A1
DZ2613A1 DZ980223A DZ980223A DZ2613A1 DZ 2613 A1 DZ2613 A1 DZ 2613A1 DZ 980223 A DZ980223 A DZ 980223A DZ 980223 A DZ980223 A DZ 980223A DZ 2613 A1 DZ2613 A1 DZ 2613A1
Authority
DZ
Algeria
Prior art keywords
piperidine compounds
new piperazine
piperazine
new
piperidine
Prior art date
Application number
DZ980223A
Other languages
English (en)
Inventor
Roelof W Feenstra
Den Jacobusa A J Hartoq
Cornelis G Kruse
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of DZ2613A1 publication Critical patent/DZ2613A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DZ980223A 1997-09-24 1998-09-22 Nouveaux composés de pipérazine et de pipéridine. DZ2613A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202950 1997-09-24

Publications (1)

Publication Number Publication Date
DZ2613A1 true DZ2613A1 (fr) 2003-03-01

Family

ID=8228755

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980223A DZ2613A1 (fr) 1997-09-24 1998-09-22 Nouveaux composés de pipérazine et de pipéridine.

Country Status (30)

Country Link
US (2) US6090812A (fr)
EP (1) EP0908458B1 (fr)
JP (1) JP4191826B2 (fr)
KR (1) KR100632188B1 (fr)
CN (1) CN1093857C (fr)
AR (1) AR017127A1 (fr)
AT (1) ATE316529T1 (fr)
AU (1) AU733526B2 (fr)
BR (1) BR9803497A (fr)
CA (1) CA2247734C (fr)
CY (1) CY1107494T1 (fr)
CZ (1) CZ296741B6 (fr)
DE (1) DE69833297T2 (fr)
DK (1) DK0908458T3 (fr)
DZ (1) DZ2613A1 (fr)
ES (1) ES2255127T3 (fr)
HU (1) HU227422B1 (fr)
ID (1) ID20895A (fr)
IL (1) IL126295A (fr)
NO (1) NO312835B1 (fr)
NZ (1) NZ331984A (fr)
PL (1) PL190622B1 (fr)
PT (1) PT908458E (fr)
RU (1) RU2197488C2 (fr)
SI (1) SI0908458T1 (fr)
SK (1) SK285205B6 (fr)
TR (1) TR199801866A1 (fr)
TW (1) TW530054B (fr)
UA (1) UA66756C2 (fr)
ZA (1) ZA988749B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534426A (ja) * 1999-01-07 2002-10-15 ワイス 鬱病の処置のための新規な１，４−二基置換されたシクロヘキサン誘導体
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
AU6392701A (en) * 2000-05-12 2001-11-20 Solvay Pharm Bv Piperazine and piperidine compounds
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
UA96756C2 (en) 2006-05-02 2011-12-12 Эббот Хелскеа Продактс Б.В. N-oxides of pyridylmethylpiperazine and -piperidine derivatives
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
WO2011088838A1 (fr) 2010-01-25 2011-07-28 H. Lundbeck A/S Nouveaux dérivés 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acéphénanthrylène en tant que ligands des récepteurs d2 de la dopamine
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
KR102359707B1 (ko) 2016-07-20 2022-02-09 노파르티스 아게 아미노피리딘 유도체 및 이의 선택적 alk-2 억제제로서의 용도
KR101665971B1 (ko) 2016-08-10 2016-10-13 (주)글로벌 로보틱스 차량용 발포패드 부착장치
TW202131926A (zh) 2019-11-22 2021-09-01 美商英塞特公司 包含alk2抑制劑及jak2抑制劑的組合療法
IL298767A (en) 2020-06-16 2023-02-01 Incyte Corp ALK2 inhibitors for the treatment of anemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (fr) * 1984-12-21 1986-06-25 Duphar International Research B.V Pipérazines bicycliques
DK93087A (da) * 1986-02-27 1987-08-28 Duphar Int Res Hidtil ukendte aryl substituerede (n-piperidinyl)methyl- og (n-piperazinyl)methylazoler med antipsykotiske egenskaber
EP0508347A1 (fr) * 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-dihydroxy-2-méthyl-8-[4-(3-hydroxy-1-(1-propyl))pipéridinyl]4H-1-benzopyran-4-one, sa préparation et son utilisation
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
JPH05262765A (ja) * 1992-03-18 1993-10-12 Sumitomo Chem Co Ltd ベンゾフラン誘導体およびそれを有効成分とする除草剤
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
EP0650964A1 (fr) 1993-11-02 1995-05-03 Duphar International Research B.V Dérivés de 1- 2H-1-benzopyran-2-one-8-yl -pipérazine
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
WO1997003067A1 (fr) * 1995-07-13 1997-01-30 Knoll Aktiengesellschaft Derives de piperazine utilises comme agents therapeutiques
PT889889E (pt) * 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
DE19637237A1 (de) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate

Also Published As

Publication number Publication date
UA66756C2 (uk) 2004-06-15
ES2255127T3 (es) 2006-06-16
JPH11302279A (ja) 1999-11-02
JP4191826B2 (ja) 2008-12-03
CZ303098A3 (cs) 1999-04-14
ZA988749B (en) 1999-03-26
RU2197488C2 (ru) 2003-01-27
NO984380L (no) 1999-03-25
AU8607998A (en) 1999-04-15
CA2247734C (fr) 2007-08-07
NO984380D0 (no) 1998-09-21
IL126295A (en) 2003-02-12
SK285205B6 (sk) 2006-08-03
NO312835B1 (no) 2002-07-08
DK0908458T3 (da) 2006-06-06
BR9803497A (pt) 2000-05-02
HU227422B1 (en) 2011-05-30
ATE316529T1 (de) 2006-02-15
US6090812A (en) 2000-07-18
NZ331984A (en) 2000-02-28
AU733526B2 (en) 2001-05-17
SK129498A3 (en) 1999-04-13
USRE41425E1 (en) 2010-07-06
CY1107494T1 (el) 2013-03-13
EP0908458A1 (fr) 1999-04-14
EP0908458B1 (fr) 2006-01-25
KR100632188B1 (ko) 2007-04-25
HK1018272A1 (en) 1999-12-17
DE69833297T2 (de) 2006-07-20
IL126295A0 (en) 1999-05-09
HUP9802129A1 (hu) 2000-03-28
ID20895A (id) 1999-03-25
CZ296741B6 (cs) 2006-06-14
AR017127A1 (es) 2001-08-22
PT908458E (pt) 2006-05-31
CA2247734A1 (fr) 1999-03-24
CN1220265A (zh) 1999-06-23
SI0908458T1 (sl) 2006-06-30
PL190622B1 (pl) 2005-12-30
CN1093857C (zh) 2002-11-06
DE69833297D1 (de) 2006-04-13
KR19990029982A (ko) 1999-04-26
TW530054B (en) 2003-05-01
HU9802129D0 (en) 1998-11-30
PL328754A1 (en) 1999-03-29
TR199801866A1 (xx) 1999-04-21

Similar Documents

Publication Publication Date Title
DZ2934A1 (fr) Nouveaux composés de pipérazine et de pipéridine.
ID17259A (id) Fluorina mengandung turunan piperidina 1,4-disubtitusikan
PT973746E (pt) 3-ciano-quinolinas substituidas
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
ID24663A (id) Turunan-turunan piperazin
DE69826891D1 (de) Piperidinderivate
DK0885212T3 (da) Quinoxalindioner
PT1036083E (pt) Novos 9a-azalidos
FR2758327B1 (fr) Nouvelles arylpiperazines derivees de piperidine
DE59811358D1 (de) Bohrvorrichtung
ID24760A (id) Turunan-turunan piridilpirol
NO992302D0 (no) Piperidin-derivater
DE69723404D1 (de) Elektrode
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
DE59801668D1 (de) Abstandhalter
FI972800A0 (fi) Behandling av signaleringsmeddelande i ATM-nod
FI973312A0 (fi) Foerfarande foer indikering av en abonnent i en kedjad V5-anslutning
DZ2446A1 (fr) Nouveaux composés
FR2760746B3 (fr) Nouveaux acylaminoacides
NO993386L (no) Elektrode
FI973582A0 (fi) Maetning av faedningsmarginal i radiosystem
FI974518A0 (fi) Sugvalsarrangemang foer pressen i en cellulosatorkmaskin
FI970798A0 (fi) List foer en avvattningsanordning i en pappersmaskin
FI974332A0 (fi) Foerfarande foer framstaellning av flerskiktselement
FI971730A0 (fi) Munstyckesarrangemang i blaoslaodan av en pappersmaskin